NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹45 Cr | ₹46 Cr | ₹41 Cr | ₹20 Cr | ₹17 Cr |
What is the latest Capital Work in Progress ratio of NEULAND LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹17 Cr |
How is Capital Work in Progress of NEULAND LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | -2.92 | |
| Mar2024 | ₹46 Cr | 13.13 | |
| Mar2023 | ₹41 Cr | 98.30 | |
| Mar2022 | ₹20 Cr | 18.59 | |
| Mar2021 | ₹17 Cr | - | |
Compare Capital Work in Progress of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹20,927.9 Cr | -1.6% | -1% | -0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,412.0 Cr | -0.4% | 6.4% | 4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,343.0 Cr | -1.5% | -4.9% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,191.0 Cr | -0.7% | 4.8% | 16.6% | Stock Analytics | |
| CIPLA | ₹122,511.0 Cr | -0.5% | 1% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,523.0 Cr | 2.2% | 6.6% | 5.7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.6% |
-1% |
-0.1% |
| SENSEX | 0.7% |
0.9% |
6.1% |
You may also like the below Video Courses